BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 31255328)

  • 1. How many lymph nodes are enough? Assessing the adequacy of lymph node yield for staging in favorable histology wilms tumor.
    Saltzman AF; Smith DE; Gao D; Ghosh D; Amini A; Aldrink JH; Dasgupta R; Gow KW; Glick RD; Ehrlich PF; Cost NG
    J Pediatr Surg; 2019 Nov; 54(11):2331-2335. PubMed ID: 31255328
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Patterns of lymph node sampling and the impact of lymph node density in favorable histology Wilms tumor: An analysis of the national cancer database.
    Saltzman AF; Carrasco A; Amini A; Aldrink JH; Dasgupta R; Gow KW; Glick RD; Ehrlich PF; Cost NG
    J Pediatr Urol; 2018 Apr; 14(2):161.e1-161.e8. PubMed ID: 29133167
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Factors affecting lymph node sampling patterns and the impact on survival of lymph node density in patients with Wilms tumor: a Surveillance, Epidemiology, and End Result (SEER) database review.
    Walker JP; Johnson JS; Eguchi MM; Saltzman AF; Cockburn M; Cost NG
    J Pediatr Urol; 2020 Feb; 16(1):81-88. PubMed ID: 31791906
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Lymph node yield in pediatric, adolescent and young adult Renal Cell Carcinoma - How many are enough?
    Saltzman AF; Smith DE; Gao D; Cost NG
    J Pediatr Surg; 2020 Oct; 55(10):2030-2034. PubMed ID: 32409174
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Outcomes of event-free survival in patients with Wilms tumor undergoing preoperative chemotherapy. Analysis of lymph-node yield in a single-center cohort.
    Flores P; Cadario M; Strambach J; Sanjuanelo M; Saleme JM; Paz E; Cacciavillano W; Felizzia G; Galluzzo L; Corbetta JP
    J Pediatr Urol; 2021 Apr; 17(2):227.e1-227.e5. PubMed ID: 33309612
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Standardizing lymph nodal sampling for Wilms tumor: A feasibility study with outcomes.
    Qureshi SS; Bhagat M; Kazi M; Kembhavi SA; Yadav S; Parambil BC; Smriti V; Baheti A; Prasad M; Khanna N; Laskar S; Vora T; Chinnaswamy G; Amin N; Ramadwar M; Talole S
    J Pediatr Surg; 2020 Dec; 55(12):2668-2675. PubMed ID: 32854922
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Lymph node involvement in Wilms tumor: results from National Wilms Tumor Studies 4 and 5.
    Kieran K; Anderson JR; Dome JS; Ehrlich PF; Ritchey ML; Shamberger RC; Perlman EJ; Green DM; Davidoff AM
    J Pediatr Surg; 2012 Apr; 47(4):700-6. PubMed ID: 22498384
    [TBL] [Abstract][Full Text] [Related]  

  • 8. How Many Lymph Nodes Are Enough? Assessing the Adequacy of Lymph Node Yield for Papillary Thyroid Cancer.
    Robinson TJ; Thomas S; Dinan MA; Roman S; Sosa JA; Hyslop T
    J Clin Oncol; 2016 Oct; 34(28):3434-9. PubMed ID: 27528716
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Assessing the adequacy of lymph node yield for different tumor stages of colon cancer by nodal staging scores.
    Wu Z; Qin G; Zhao N; Jia H; Zheng X
    BMC Cancer; 2017 Jul; 17(1):498. PubMed ID: 28743236
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The re-evaluation of optimal lymph node yield in stage II right-sided colon cancer: is a minimum of 12 lymph nodes adequate?
    Cai Y; Cheng G; Lu X; Ju H; Zhu X
    Int J Colorectal Dis; 2020 Apr; 35(4):623-631. PubMed ID: 31996986
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Development and external validation of a pathological nodal staging score for patients with clear cell renal cell carcinoma.
    Rieken M; Boorjian SA; Kluth LA; Capitanio U; Briganti A; Thompson RH; Leibovich BC; Krabbe LM; Margulis V; Raman JD; Regelman M; Karakiewicz PI; Rouprêt M; Abufaraj M; Foerster B; Gönen M; Shariat SF
    World J Urol; 2019 Aug; 37(8):1631-1637. PubMed ID: 30406477
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Impact of lymph node evaluation in adjuvant and neoadjuvant chemotherapy settings on survival outcomes in Wilms tumour: a review of 185 cases from a single institution.
    Nanda RH; Shehata BM; Khoshnam N; Durham M; Kim S; Selwanes W; Chen Z; Zhang C; Esiashvili N
    Pathology; 2017 Jan; 49(1):19-23. PubMed ID: 27913041
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pathologic node-negative lung cancer: Adequacy of lymph node yield and a tool to assess the risk of occult nodal disease.
    Tan KS; Hsu M; Adusumilli PS
    Lung Cancer; 2022 Dec; 174():60-66. PubMed ID: 36334358
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prognostic impact of lymph node involvement and loss of heterozygosity of 1p or 16q in stage III favorable histology Wilms tumor: A report from Children's Oncology Group Studies AREN03B2 and AREN0532.
    Evageliou N; Renfro LA; Geller J; Perlman E; Kalapurakal J; Paulino A; Dix D; Eklund MJ; Murphy AJ; Romao RLP; Ehrlich PF; Varela CR; Vallance K; Fernandez CV; Dome JS; Mullen EA
    Cancer; 2024 Mar; 130(5):792-802. PubMed ID: 37902955
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Outcome and Prognostic Factors in Stage III Favorable-Histology Wilms Tumor: A Report From the Children's Oncology Group Study AREN0532.
    Fernandez CV; Mullen EA; Chi YY; Ehrlich PF; Perlman EJ; Kalapurakal JA; Khanna G; Paulino AC; Hamilton TE; Gow KW; Tochner Z; Hoffer FA; Withycombe JS; Shamberger RC; Kim Y; Geller JI; Anderson JR; Grundy PE; Dome JS
    J Clin Oncol; 2018 Jan; 36(3):254-261. PubMed ID: 29211618
    [TBL] [Abstract][Full Text] [Related]  

  • 16. External validation of the pathological nodal staging score in upper tract urothelial carcinoma: A population-based study.
    Xylinas E; Kluth L; Rieken M; Rouprêt M; Al Hussein Al Awamlh B; Clozel T; Sun M; Karakiewicz PI; Gonen M; Shariat SF
    Urol Oncol; 2017 Jan; 35(1):33.e21-33.e26. PubMed ID: 27816402
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinicopathologic findings predictive of relapse in children with stage III favorable-histology Wilms tumor.
    Ehrlich PF; Anderson JR; Ritchey ML; Dome JS; Green DM; Grundy PE; Perlman EJ; Kalapurakal JA; Breslow NE; Shamberger RC
    J Clin Oncol; 2013 Mar; 31(9):1196-201. PubMed ID: 23382471
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Factors related to lymph node sampling at the time of surgery in children, adolescents, and young adults with unilateral non-metastatic renal cell carcinoma.
    Saltzman AF; Stokes W; Walker J; Cost NG
    J Pediatr Urol; 2019 May; 15(3):259.e1-259.e7. PubMed ID: 30819622
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Correlation between preoperative staging computerized tomography and pathological findings after nodal sampling in children with Wilms tumor.
    Lubahn JD; Cost NG; Kwon J; Powell JA; Yang M; Granberg CF; Wickiser JE; Rakheja D; Gargollo PC; Baker LA; Margulis V
    J Urol; 2012 Oct; 188(4 Suppl):1500-4. PubMed ID: 22910268
    [TBL] [Abstract][Full Text] [Related]  

  • 20. How to evaluate the adequacy of staging for nodal-negative epithelial ovarian cancer? Use of nodal staging score.
    Xu Y; Li H; Tong X; Pang Y; Tong X; Li L; Cheng L
    J Gynecol Oncol; 2019 Mar; 30(2):e21. PubMed ID: 30740953
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.